Grand Rounds July 29, 2022: Effect of Early Treatment With Single-Dose Pegylated Interferon Lambda Among Patients With COVID-19: Results From The TOGETHER Trial (Edward Mills, PhD, FRCP; Jeffrey S. Glenn, MD, PhD)
Rethinking Clinical Trials
AUGUST 4, 2022
McMaster University, Canada. The arm evaluating Peginterferon Lambda is a multicenter, investigator sponsored, randomized placebo-controlled Phase 3 study in Brazil with 12 sites and Canada (5 sites). Edward Mills, PhD, FRCP. Department of Health Research Methods, Evidence & Impact. Glenn, MD, PhD. Stanford University. Key Points.
130 
Let's personalize your content